---
title: "NP49425 Generic and Biosimilar Transition Medicines"
ocid: "ocds-r6ebe6-0000801883"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000801883"
markdown_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000801883.md"
json_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000801883.json"
source: "Public Contracts Scotland"
current_stage: "Planning"
buyer: "THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)"
published: "2025-08-05"
---

# NP49425 Generic and Biosimilar Transition Medicines

Buyer: THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)  
Current stage: Planning  
OCID: ocds-r6ebe6-0000801883

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000801883)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-r6ebe6-0000801883.json)

## Summary

The Common Services Agency, commonly known as NHS National Services Scotland (NSS), is in the planning stage of a procurement process titled "NP49425 Generic and Biosimilar Transition Medicines". This tender focuses on the health industry category, specifically the procurement of medicines transitioning from exclusivity. Located in Edinburgh, UKM, this opportunity is intended to establish a framework agreement for supplying a range of medicines, such as Apremilast, Axitinib, and Denosumab. The process is being initiated as a tender with a communication notice expected on 15th August 2025, and will be governed by regulations pertinent to EU procurement standards. Potential suppliers should be attentive to the framework's considerable estimated value of £131,244,104 and the 48-month duration.

This tender presents significant opportunities for pharmaceutical manufacturers and suppliers, particularly those specialising in generic and biosimilar medicines, to expand their business with NHS Scotland. The framework agreement is designed to be a multi-supplier arrangement, thus allowing multiple businesses the opportunity to participate and supply different medicine categories. Companies with expertise in producing or distributing health-related goods, especially within the categories of oncology, cytokine modulators, cardiovascular, and other specialised medicines, will find this tender a competitive avenue for growth. The procurement encourages innovation and competitive pricing, potentially offering a substantial market foothold for successful bidders in the public health sector.

## Notice

The Authority seeks to establish a Framework Agreement covering medicines that are imminently approaching or have already reached Loss of Exclusivity (LoE). The range of medicines under consideration for inclusion in the Framework Agreement are listed below (subject to removal or replacement due to a continually shifting litigation landscape): - Apremilast 30mg tablets - Axitinib 1mg tablets - Axitinib 3mg tablets - Axitinib 5mg tablets - Axitinib 7mg tablets - Betaine oral powder - Denosumab 120mg/1.7ml solution for injection vials - Denosumab 120mg/1ml solution for injection pre-filled syringes - Denosumab 60mg/1ml solution for injection pre-filled syringes - Eltrombopag 25mg oral powder sachets sugar free - Eltrombopag 25mg tablets - Eltrombopag 50mg tablets - Eltrombopag 75mg tablets - Ferric carboxymaltose 100mg/2ml dispersion for injection vials - Ferric carboxymaltose 1g/20ml dispersion for injection vials - Ferric carboxymaltose 500mg/10ml dispersion for injection vials - Fluticasone furoate 27.5micrograms/dose nasal spray - Fluticasone propionate 50micrograms/dose / Azelastine 137micrograms/dose nasal spray - Generic Otezla tablets treatment initiation pack - Generic Sustanon 250mg/1ml solution for injection ampoules - Golimumab 100mg/1ml solution for injection pre-filled disposable devices - Golimumab 50mg/0.5ml solution for injection pre-filled disposable devices - Golimumab 50mg/0.5ml solution for injection pre-filled syringes - Lanreotide 120mg/0.5ml solution for injection pre-filled syringes - Lanreotide 90mg/0.5ml solution for injection pre-filled syringes - Lanreotide 60mg/0.5ml solution for injection pre-filled syringes - Mesalazine 1.5g gastro-resistant modified-release granules sachets sugar free - Mesalazine 1.6g gastro-resistant tablets - Mesalazine 1g gastro-resistant modified-release granules sachets sugar free - Mesalazine 1g modified-release granules sachets sugar free - Mesalazine 1g modified-release tablets - Mesalazine 1g suppositories - Mesalazine 1g/100ml enema - Mesalazine 1g/application foam enema - Mesalazine 250mg gastro-resistant tablets - Mesalazine 2g modified-release granules sachets sugar free - Mesalazine 2g/59ml enema - Mesalazine 400mg gastro-resistant tablets - Mesalazine 4g modified-release granules sachets sugar free - Mesalazine 500mg gastro-resistant modified-release granules sachets sugar free - Mesalazine 500mg gastro-resistant tablets - Mesalazine 500mg suppositories - Mesalazine 800mg gastro-resistant tablets - Nilotinib 150mg capsules - Nilotinib 200mg capsules - Nilotinib 50mg capsules - Nintedanib 100mg capsules - Nintedanib 150mg capsules - Omalizumab 150mg/1ml solution for injection pre-filled syringes - Omalizumab 75mg/0.5ml solution for injection pre-filled syringes - Omalizumab 300mg/2ml solution for injection pre-filled disposable devices - Omalizumab 300mg/2ml solution for injection pre-filled syringes - Pazopanib 200mg tablets - Pazopanib 400mg tablets - Perampanel 10mg tablets - Perampanel 12mg tablets - Perampanel 2mg tablets - Perampanel 4mg tablets - Perampanel 500micrograms/ml oral suspension sugar free - Perampanel 6mg tablets - Perampanel 8mg tablets - Pertuzumab 420mg/14ml solution for infusion vials 1 vial - Testosterone undecanoate 1g/4ml solution for injection ampoules - Testosterone undecanoate 1g/4ml solution for injection vials - Ticagrelor 60mg tablets - Ticagrelor 90mg orodispersible tablets sugar free - Ticagrelor 90mg tablets - Tocilizumab 162mg/0.9ml solution for injection pre-filled disposable devices - Tocilizumab 162mg/0.9ml solution for injection pre-filled syringes - Tocilizumab 200mg/10ml solution for infusion vials - Tocilizumab 400mg/20ml solution for infusion vials - Tocilizumab 80mg/4ml solution for infusion vials - Trabectedin 1mg powder for solution for infusion vials - Trabectedin 250microgram powder for solution for infusion vials

### Lot Information

Cancer Medicines (Group 2)

Supply of cancer medicines (Group 2) to NHS Scotland. The Authority intends to award this Lot as an unranked multi supplier Framework Agreement per product line. Full details of Goods and volumes will be found within the ITT documents once published.

Cytokine Modulators

Supply of cytokine modulators to NHS Scotland. The Authority intends to award this Lot as an unranked multi supplier Framework Agreement per product line. Full details of Goods and volumes will be found within the ITT documents once published.

Gastrointestinal, Endocrine, Nutrition, Blood, and Multiple Sclerosis Medicines

Supply of gastrointestinal, endocrine, nutrition, blood, and multiple sclerosis medicines NHS Scotland. The Authority intends to award this Lot as a ranked multi supplier Framework Agreement per product line. Full details of Goods and volumes will be found within the ITT documents once published.

Denosumab (osteoporosis)

Supply of denosumab (osteoporosis) to NHS Scotland. The Authority intends to award this Lot as an unranked multi supplier Framework Agreement per product line. Full details of Goods and volumes will be found within the ITT documents once published.

Apremilast

Supply of apremilast to NHS Scotland. The Authority intends to award this Lot as a ranked multi supplier Framework Agreement per product line. Full details of Goods and volumes will be found within the ITT documents once published.

Cardiovascular and Respiratory Medicines

Supply of cardiovascular and respiratory medicines to NHS Scotland. The Authority intends to award this Lot as a ranked multi supplier Framework Agreement per product line. Full details of Goods and volumes will be found within the ITT documents once published.

Nintedanib

Supply of nintedanib to NHS Scotland. The Authority intends to award this Lot as a ranked multi supplier Framework Agreement per product line. Full details of Goods and volumes will be found within the ITT documents once published.

Cancer Medicines (Group 1)

Supply of cancer medicines (Group 1) to NHS Scotland. The Authority intends to award this Lot as a ranked multi supplier Framework Agreement per product line. Full details of Goods and volumes will be found within the ITT documents once published.

Neurology Medicines

Supply of neurology medicines to NHS Scotland. The Authority intends to award this Lot as a ranked multi supplier Framework Agreement per product line. Full details of Goods and volumes will be found within the ITT documents once published.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Public Contracts Scotland |
| Latest notice | https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=AUG536302 |
| Notice type | OJEU - F1 - Prior Information Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Not Specified |
| Procurement method details | Not specified |
| Tender suitability | Not specified |
| Awardee scale | Not specified |
| All stages | Planning |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 5 Aug 2025 |
| Submission deadline | Not specified |
| Future notice date | 15 Aug 2025 |
| Award date | Not specified |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £131,244,104 |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | Not specified |

## Status

| Field | Value |
| --- | --- |
| Tender status | Planned |
| Lots status | Planned |
| Awards status | Not specified |
| Contracts status | Not specified |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS) |
| Locality | EDINBURGH |
| Post town | Edinburgh |
| Postcode | EH12 9EB |
| Country | Scotland |
| ITL 1 | TLM Scotland |
| ITL 2 | TLM1 East Central Scotland |
| ITL 3 | TLM13 City of Edinburgh |
| Local authority | City of Edinburgh |
| Electoral ward | Drum Brae/Gyle |
| Westminster constituency | Edinburgh South West |
| Delivery location | TLM Scotland |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 5 Aug 2025 at 00:00 - Planning - OJEU - F1 - Prior Information Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=AUG536302

## Documents

- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=AUG536302
  NP49425 Generic and Biosimilar Transition Medicines - The Authority seeks to establish a Framework Agreement covering medicines that are imminently approaching or have already reached Loss of Exclusivity (LoE). The range of medicines under consideration for inclusion in the Framework Agreement are listed below (subject to removal or replacement due to a continually shifting litigation landscape): - Apremilast 30mg tablets - Axitinib 1mg tablets - Axitinib 3mg tablets - Axitinib 5mg tablets - Axitinib 7mg tablets - Betaine oral powder - Denosumab 120mg/1.7ml solution for injection vials - Denosumab 120mg/1ml solution for injection pre-filled syringes - Denosumab 60mg/1ml solution for injection pre-filled syringes - Eltrombopag 25mg oral powder sachets sugar free - Eltrombopag 25mg tablets - Eltrombopag 50mg tablets - Eltrombopag 75mg tablets - Ferric carboxymaltose 100mg/2ml dispersion for injection vials - Ferric carboxymaltose 1g/20ml dispersion for injection vials - Ferric carboxymaltose 500mg/10ml dispersion for injection vials - Fluticasone furoate 27.5micrograms/dose nasal spray - Fluticasone propionate 50micrograms/dose / Azelastine 137micrograms/dose nasal spray - Generic Otezla tablets treatment initiation pack - Generic Sustanon 250mg/1ml solution for injection ampoules - Golimumab 100mg/1ml solution for injection pre-filled disposable devices - Golimumab 50mg/0.5ml solution for injection pre-filled disposable devices - Golimumab 50mg/0.5ml solution for injection pre-filled syringes - Lanreotide 120mg/0.5ml solution for injection pre-filled syringes - Lanreotide 90mg/0.5ml solution for injection pre-filled syringes - Lanreotide 60mg/0.5ml solution for injection pre-filled syringes - Mesalazine 1.5g gastro-resistant modified-release granules sachets sugar free - Mesalazine 1.6g gastro-resistant tablets - Mesalazine 1g gastro-resistant modified-release granules sachets sugar free - Mesalazine 1g modified-release granules sachets sugar free - Mesalazine 1g modified-release tablets - Mesalazine 1g suppositories - Mesalazine 1g/100ml enema - Mesalazine 1g/application foam enema - Mesalazine 250mg gastro-resistant tablets - Mesalazine 2g modified-release granules sachets sugar free - Mesalazine 2g/59ml enema - Mesalazine 400mg gastro-resistant tablets - Mesalazine 4g modified-release granules sachets sugar free - Mesalazine 500mg gastro-resistant modified-release granules sachets sugar free - Mesalazine 500mg gastro-resistant tablets - Mesalazine 500mg suppositories - Mesalazine 800mg gastro-resistant tablets - Nilotinib 150mg capsules - Nilotinib 200mg capsules - Nilotinib 50mg capsules - Nintedanib 100mg capsules - Nintedanib 150mg capsules - Omalizumab 150mg/1ml solution for injection pre-filled syringes - Omalizumab 75mg/0.5ml solution for injection pre-filled syringes - Omalizumab 300mg/2ml solution for injection pre-filled disposable devices - Omalizumab 300mg/2ml solution for injection pre-filled syringes - Pazopanib 200mg tablets - Pazopanib 400mg tablets - Perampanel 10mg tablets - Perampanel 12mg tablets - Perampanel 2mg tablets - Perampanel 4mg tablets - Perampanel 500micrograms/ml oral suspension sugar free - Perampanel 6mg tablets - Perampanel 8mg tablets - Pertuzumab 420mg/14ml solution for infusion vials 1 vial - Testosterone undecanoate 1g/4ml solution for injection ampoules - Testosterone undecanoate 1g/4ml solution for injection vials - Ticagrelor 60mg tablets - Ticagrelor 90mg orodispersible tablets sugar free - Ticagrelor 90mg tablets - Tocilizumab 162mg/0.9ml solution for injection pre-filled disposable devices - Tocilizumab 162mg/0.9ml solution for injection pre-filled syringes - Tocilizumab 200mg/10ml solution for infusion vials - Tocilizumab 400mg/20ml solution for infusion vials - Tocilizumab 80mg/4ml solution for infusion vials - Trabectedin 1mg powder for solution for infusion vials - Trabectedin 250microgram powder for solution for infusion vials

## Notice URLs

- http://
- http://www.nss.nhs.scot/browse/procurement-and-logistics
- http://www.publiccontractsscotland.gov.uk/Search/Search_Switch.aspx?ID=801883
- https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000801883

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000801883. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-r6ebe6-0000801883.json.